Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction

Tamás Radovits, Leila Seres, Domokos Gero, Irina Berger, Csaba Szabó, Matthias Karck, Gábor Szabó

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds